Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

Ikaria Holdings Inc Products   
6 State Rte 173
Clinton,  NJ  08809
United States
Telephone: (908) 238-6600
Toll Free Number: (877) 566-9466
Fax: (908) 238-6633
URL: http://www.ikaria.com
Email: info@ikaria.com

Ikaria (TM) Holdings Incorporated, based in Clinton, New Jersey, is a privately held biotherapeutics company that was formed with the 2007 merger of Ikaria Incorporated, established in 2005, and INO Therapeutics. Ikaria Incorporated's technology was based on metabolic control research conducted by Ikaria Incorporated founder Dr. Mark Roth. INO Therapeutics originally was known for its INOmax (R) nitric oxide pharmaceutical gas, introduced in 1999. It also is developing the Covox (R) carbon monoxide therapeutic agent. Ikaria Holdings focuses on developing critical care therapies. It is pursuing research on metabolic depression treatments. The company is developing and acquiring new drugs, devices, and integrated drug and device systems. It provides business partners with clinical research, device development, manufacturing, marketing, and other services. A manufacturing facility, based in Madison, Wisconsin, produces drug delivery devices.

Org. Type: Corporation Equity Type: Private
Company Status: Active

Products:
Ikaria Holdings Inc--Company Reference

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.